Skip to main content

Dalteparin safely used for 12 months to prevent VTE recurrence in cancer patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Dalteparin safely used for 12 months to prevent VTE recurrence in cancer patients

User login

Username

Password

Reset your password

Type	Lead	score